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Abstract
Asthma is a chronic inflammatory disease of the airways and the mechanisms are not fully 
understood. Myeloid-derived suppressor cells (MDSCs) are a heterogeneous group of monocytes, 
granulocyte and myeloid cells at early stage of differentiation. They possess phenotypic plasticity 
and regulate airway inflammation. We recently reported that Kruppel-like factor 4 (KLF4) 
regulates MDSC differentiation into fibrocytes, emerging effectors in chronic inflammation. 
However, the role of KLF4 in asthma is not known. Thymic stromal lymphopoietin (TSLP) is an 
epithelial cell-derived cytokine and a key initiator of allergic airway inflammation. Given the fact 
that TSLP promotes Th2 cytokine production that increases MDSC differentiation into fibrocytes, 
we postulate that KLF4 regulates asthma in a TSLP-dependent manner. In this study, we utilized a 
model of allergic asthma with ovalbumin challenge (OVA). We found that upon OVA treatment the 
wild type mice had increased MDSC infiltration into the lung, up-regulation of KLF4 and TSLP 
gene expression, and higher levels of Th2 cytokines including IL4 and IL13. Consistently, lack of 
KLF4 expression in monocytes and lung epithelial cells resulted in decreased TSLP expression 
and lower levels of Th2 cytokines in mice, and fibrocyte generation was compromised. KLF4 
deficiency in these cells also led to decreased airway hyperresponsiveness (AHR), a cardinal 
feature of asthma, as assessed by whole body plethysmography. Moreover, lung fibrosis as 
measured by trichome staining was attenuated and the population of CD45+COL1A1+ fibrocytes 
was diminished in this setting. Together, our results suggest that KLF4 regulates asthma 
development in a TSLP- and fibrocyte-dependent manner.
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Introduction
Asthma is a heterogeneous inflammatory disease of the airways [1] affecting more than 22 
million people in the US [2]. It is characterized by airway remodeling, a structural 
dysfunction potentially affected by epithelial-mesenchymal transition (EMT) and modified 
by type 2 inflammation [3,4]. Optimal control of asthma requires inhibition of both the 
inflammatory and structural components of the asthma response.
Myeloid-derived suppressor cells (MDSCs) are a heterogeneous group of monocytes that 
possess phenotypic plasticity [5]. They are master regulators of the airway inflammation 
which precedes asthma [6]. However, how MDSCs regulate asthma remains largely 
unknown [7]. Recently, MDSCs showed a high potential to differentiate into fibrocytes in 
response to Th2 cytokines [8]. It is now understood that fibrocytes are emerging effectors in 
chronic inflammation [9] and are precursors of myofibroblasts critical to airway remodeling 
in asthma [10]. Therefore, the presence of fibrocytes in chronic asthmatic lungs [11] 
suggests that MDSCs not only execute their immune function to regulate airway 
inflammation in the early stage of asthma, but also promote airway remodeling after they 
adopt a fibrocyte fate. However, whether fibrocyte generation from MDSCs is modulated by 
airway epithelial cells, and contributes to EMT, is not clear.
Thymic stromal lymphopoietin (TSLP) is an epithelial-cell-derived cytokine and a key 
initiator of allergic airway inflammation [12]. It regulates many types of cells, including Th2 
cells in asthma. In a recent phase II clinical trial, a human anti-TSLP monoclonal antibody 
reduced allergen-induced bronchoconstriction and indexes of airway inflammation [13]. 
These results indicated a pivotal role of TSLP in allergen-induced airway responses in 
patients with allergic asthma. However, this antibody led to significant adverse events. Thus, 
there is an urgent need to study the precise function of TSLP in asthma before developing 
TSLP-specific interventions in patients. The fact that TSLP promotes the production of Th2 
cytokines [14], which is critical to fibrocyte generation [15] suggests that TSLP may induce 
the asthmatic response in a fibrocyte-dependent manner.
We recently reported that fibrocyte generation from MDSCs was regulated by KLF4 [16,17], 
a transcription factor cloned in epithelial cells. KLF4 is also expressed in hematopoietic cells 
and critical to inflammation [18] and monocyte differentiation [19]. The role of KLF4 in 
asthma pathogenesis has not been explored. In the current study, we tested our hypothesis 
that KLF4 in monocytes and epithelial cells promotes the asthmatic response by affecting 
TSLP-dependent fibrocyte generation from MDSCs in the airway.
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1. Materials and methods
2.1 A Mouse model of allergic asthma
Six to eight weeks old female BALB/c mice, weighing 20±2 g, were purchased from 
Jackson Laboratory (Bar Harbor, ME, USA). All mice were housed under specific pathogen- 
and ovalbumin (OVA)-free conditions. All experimental mice used in this study were kept 
under a protocol approved by the Institutional Animal Care and Use Committee at 
University of South Carolina School of Medicine. Mice were evenly divided into two groups 
and challenged either with PBS or OVA. Specifically, they were sensitized on Days 0 and 7 
by an intraperitoneal injection of a mixture containing 50 μg of ovalbumin (OVA; Grade V, 
Sigma) and 1 mg of Al(OH)3 (Alum) in PBS (a total volume of 0.2 ml). On Day 14, mice 
were challenged intranasally (i.n.) with 40 μL of 0.03%OVA in PBS (OVA) or PBS alone 
(PBS). The mice were sacrificed on day 17 for various analyses (Fig 1A). The control 
animals received two immunizations with OVA/Alum and six challenges with PBS. In 
addition, KLF4 deficient mice were used in the study. These mice were generated by 
crossing fibroblast specific protein 1 promoter (FSP-1)-Cre transgenic mice on BalB/c 
background (Jackson) with our KLF4(flox) mice form our laboratory.
2.2 Immunohistochemistry (IHC)
Serial sections of lung tissues on charged glass slides were rehydrated through xylene and 
ethanol to water, subjected to antigen retrieval and stained with the KLF4 antibodies as 
described previously [16]. Goblet hyperplasia was evaluated by Periodic Acid Schiff (PAS) 
staining [20], and lung fibrosis was assessed by Masson’s trichrome staining [21]. Images 
were captured on an Olympus microscope, model BX51 equipped with a digital camera and 
Optronics Version 1.2 software. All slides were evaluated by a board certified pathologist, 
who is blind and independent on this study.
2.3 Cytokine measurement using bronchoaveolar lavage fluid (BALF)
BALF was collected as previously described by others [22]. Cytokines present in the BALF 
were analyzed using a Bio-Plex Pro™ 23-Plex panel (Bio-Rad) according to the 
manufacturer protocol. Duplicate samples were analyzed from each animal. Data were 
represented using Microsoft Excel.
2.4 Flow Cytometry
Lung mononuclear cells were isolated and purified after collagenase digestion as described 
previously [23]. After further purification, the lung mononuclear cells were incubated with 
different antibodies including CD11b, Ly6G, CD45 (eBioscience), and Col1A1 (Rockland 
Immunochemicals, Inc) and then analyzed with a BD FACS Aria II flow cytometer.
2.5 Quantitative RT-PCR
Lung tissue was collected, frozen in liquid nitrogen, and then stored at −80°C. Total RNA 
was extracted with Trizol Reagent (Invitrogen). cDNAs were synthesized by reverse 
transcriptase MML-V (Promega) followed by quantitative real-time PCR analysis with 
specific primers for KLF4, FSP1, CCR2, and TSLP and SYBR Green master mix (Biorad). 
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GAPDH was used as a normalization control. Primer sequences were as the following: 
mKLF4 (forward: 5′-CCGGCGGGAAGGGAGAAGA-3′, reverse: 5′-
GCTAGGAGGGCCGGGTTGTTAC-3′), mFSP1 (forward: 5′-
AGCTGAACAAGACAGAGCTC-3′, reverse: 5′-ACAGGAAGACACAGTACTCC-3′), 
mCCR2 (forward 5′-ATTCTCCACACCCTGTTTCG-3′, reverse 5′-
ATGCAGCAGTGTGTCATTCC-3′: reverse:), mTSLP (forward: 5′-
CTGAGAGAAATGACGGTACTCAGG-3′, reverse: 5′-
GGAGATTGCATGAAGGAATACCAC-3′), mGAPDH (forward: 5′-
AGGCCGGTGCTGCTGAGTATGTC-3′, reverse: 5′-CAGAAGGGGCGGAGATGAT-3′).
2.6 Airway resistance measurement
The airway resistance to inhaled methacholine (MCh; Sigma-Aldrich) was measured using 
the Buxco Finepoint NAM System (TBL4999, Buxco, CT) 48 hours after the last OVA 
challenge in mice by following the protocol from the manufacturer. It is designed to measure 
airway mechanics by non-invasive whole body plethysmography. Briefly, after a short 
acclimation to the chamber, the mice received an initial baseline challenge of saline, 
followed by increasing doses of nebulized methacholine. During exposure to methacholine, 
each mouse was given either 0 (saline), 6.25, or 12.5 mg/ml of Mch, followed by continuous 
measurement of specific airway resistance (sRaw) for 3 minutes. The airway responses to 
the inhaled MCh were recorded by a computer.
2.7 Statistical Analysis
For in vivo studies, each group consisted of three mice. In vitro assays were performed in 
triplicates. Data is represented as mean ± SEM. Data were analyzed using t test (two-group 
comparison) or one-way ANOVA (multi-group comparison). A p-value < 0.05 was 
considered to indicate statistical significance.
2. Results
3.1. Increased goblet cell hyperplasia was linked with up-regulation of KLF4 in a mouse 
model of allergic asthma
The important role of MDSCs in asthma [6,24] and KLF4’s regulation of MDSCs from our 
tumor studies [25] prompted us to hypothesize that KLF4 may be involved in asthma 
development. To this end, we utilized an acute mouse model of allergic asthma as described 
in the Materials and Methods (Fig 1A). After ovalbumin challenge, goblet cell hyperplasia in 
the airway of the mice, a feature of asthma pathogenesis from previous studies, was 
prominent when compared to that of the control mice (pointed by arrow heads in Fig 1B). 
Consistent with the requirement of KLF4 in goblet cell development, KLF4 expression was 
shown to be increased using immunohistochemistry (IHC) in the airway epithelium. As 
shown in Fig 1C, there were three KLF4-staining positive cells in the epithelium of the 
control group. This number was significantly increased (32) in the OVA challenged group.
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3.2 Increased levels of Th2 cytokines were associated with infiltration of more MDSCs and 
up-regulation of KLF4 and TSLP in allergic asthma
Levels of Th2 cytokines often increase in the pathogenesis of asthma. Indeed, in our allergic 
mouse model of asthma, IL4 levels in the bronchoaveolar lavage fluid (BALF) increased 
from 22 ng/ml to 45 ng/ml and IL13 levels increased from 62ng/ml to 92ng/ml (Fig 2A, 
p<0.05). To examine whether Th2 cytokine induction was associated with MDSC 
recruitment, we analyzed single cells purified from the lung tissues by flow cytometry using 
CD11b and Ly6G as markers of MDSCs. As shown in Fig 2B, while the MDSCs are 5.4% in 
the control lungs, this number increased to 14.6% in OVA challenged lung tissues. In 
addition, we performed qRT-PCR analysis to examine the expression of KLF4 and TSLP, 
the latter is a key initiator of airway inflammation in allergic asthma. As expected, mRNA 
levels of both KLF4 and TSLP increased to 2–3 folds upon OVA challenge (Fig 2C).
3.3. KLF4 ablation in CCR2+MDSCs in mice reduced TSLP expression in the lung and 
attenuated fibrocyte generation
We recently reported that KLF4 was highly expressed in CCR2+MDSCs [17]. This, coupled 
with increased MDSCs upon allergic asthma challenge (Fig 2B), led us to postulate that 
KLF4 in CCR2+MDSCs may directly regulate the pathogenesis of allergic asthma. To test 
this possibility, we sought to generate a knockout mouse model in which KLF4 was 
specifically ablated in CCR2+MDSCs. Due to the highest expression level of FSP-1 being 
present in CCR2+MDSCs among all MDSC subpopulations ([17] and data not shown), we 
elected to cross FSP-1-Cre transgenic mice with KLF4 (flox) mice to generate an FSP-1-
Cre/KLF4 (flox) conditional knockout mouse model. KLF4 knockout in monocytes in 
FSP-1-Cre/KLF4 (flox) mice (KLF4−/−) was demonstrated by qRT-PCR using RNA samples 
purified from the blood monocytes (Fig 3A). KLF4 deficiency was also linked with 
significant low expression of FSP-1 and CCR2 in the blood, and TSLP in the lung. TSLP is 
mainly expressed in keratinocytes and epithelial cells [14]. Down-regulation of TSLP in 
KLF4−/− mice led us to hypothesize that KLF4−/− mice also possessed KLF4 deficiency in 
these cells. Indeed, IHC showed absence of KLF4 staining in skin keratinocytes (data not 
shown), and the numbers of KLF4-positive cells decreased by ~80% in the airway 
epithelium of KLF4−/− mice (Fig 3B). To examine the potential immunological defects in 
KLF4−/− mice, we measured the cytokine/chemokine levels in sera. Levels of IL-4 and IL-5 
were significantly increased, but levels of IL-12 (P40), a shared subunit of IL-12 and IL-23 
[26], were decreased (Fig 3C). The roles of IL-4 and IL-5 in the polarization of Th2 cells 
[27] and IL-12(P40) in the polarization of Th1 cells [28] suggest that KLF4 ablation in 
FSP-1-expressing cells promotes Th2 cell polarization. Interestingly, the levels of 
granulocyte colony-stimulating factor (G-CSF) and macrophage inflammatory protein 1 
alpha (MIP-1α) were also significantly increased in KLF4 null mice (Fig 3C). Given the 
association of G-CSF and MIP MIP-1α with monocytic MDSC generation [29] or migration 
[30,31], these data suggest that KLF4 in FSP-1-expressing cells regulates the function of 
CCR2+MDSCs. In agreement with this possibility and consistent with a role of 
CCR2+MDSCs in fibrocyte generation [17], the number of fibrocytes generated from 
splenocytes decreased from 112±8 (per 105 cells) in the WT mice to 46±4 (per 105 cells) in 
KLF4−/− mice (Fig 3D).
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3.4. KLF4 deficiency attenuated AHR and fibrosis accompanied by significantly decreased 
population of pulmonary fibrocytes in an acute mouse model of allergic asthma
To examine the effect of KLF4 deficiency on allergic asthma, we sensitized six female wild 
type BalB/c mice (WT) and six female FSP-1-Cre/KLF4 (flox) mice (KLF4−/−) at 6–8 
weeks old. Mice were evenly divided into two subgroups and challenged either with PBS or 
OVA as described in Fig 1. Three days later, the mice were loaded into the Buxco Finepoint 
NAM system (TBL4999) to measure airway mechanics. To obtain a dose response curve, 
stepwise increasing concentrations of methacholine were administered, followed by 
continuous measurement of specific airway resistance (sRaw). The OVA challenge increased 
the sRaw for about 32% in the WT mice at the dosage of 12.5mg/ml MCh. However, while 
the unchallenged KLF4−/− mice had decreased sRaw, the OVA challenge did not increase the 
sRaw at the same dosage of MCh (Fig 4A). Similarly, the level of Th2 cytokine IL-13 was 
almost doubled upon OVA challenge as measured by qRT-PCR (Fig 4B). However, in the 
KLF4−/− mice, while the basal level of IL-13 slightly increased (Fig 4C), most likely due to 
Th2-biased development in the mice, the OVA challenge did not increase IL-13 expression. 
In agreement with the sRaw data, Trichrome staining suggested increased fibrosis in the 
subepithelial areas upon OVA challenge in the WT mice, but there were no differences 
between the basal and the OVA challenged airways in KLF4− /− mice (Fig 4C). In addition, 
CCR2+MDSCs increased from 5.9% to 9.5% after OVA challenge in the WT mice. In the 
KLF4−/− mice, basal levels of CCR2+MDSCs were increased to 12.3%. However, OVA 
challenge did not alter the population of these cells (Fig 4D). Furthermore, consistent with 
the increased CCR2+MDSCs in the WT mice after OVA challenge, CD45+COL1A1+ 
fibrocytes also increased. Surprisingly, the elevated basal population of CCR2+MDSCs in 
KLF4−/− mice was not associated with increased numbers of fibrocytes. Upon OVA 
challenge, there was no increase of CCR2+MDSCs, but the fibrocyte population decreased 
by more than 50% in KLF4−/− mice (Fig 4E).
3. Discussion
Although our data clearly showed that KLF4 is involved in airway inflammation and 
remodeling, the specific role of KLF4 in asthma appears to be complex. In the wild type 
mice, KLF4 expression is upregulated upon allergen challenge along with severity of disease 
(Fig 1 and 2), which may suggest that KLF4 promotes asthma. In addition, the increased 
infiltration of MDSCs in this setting is aligned with the role of KLF4 in recruitment of 
MDSCs. However, in KLF4 deficient mice, the basal level of MDSCs increased (Fig 4D), 
but specific airway resistance (sRaw) as measured by whole body plethysmography was 
decreased. This is not consistent with the role of KLF4 in promoting asthma and the role of 
KLF4 in MDSC recruitment. On the other hand, in KLF4 deficient mice, the asthma 
responses upon OVA challenge, including the sRAW, fibrotic progression, IL13 up-
regulation, and enrichment of MDSCs and fibrocytes are significantly disrupted (Fig 4). 
Together, out data support the hypothesis that KLF4 has different roles in initiation and 
progression of asthma at least in the allergic asthma model. Additional asthma models, 
including chronic asthma mouse models and allergic mouse models with different allergen 
challenge [32] need to be used to confirm our observations in future studies. At a cellular 
level, we found that in the progression of asthma upon OVA challenge, upregulated KLF4 
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expression is linked with high levels of MDSCs (Fig 1) which was supported by reduced 
levels of MDSCs and fibrocytes in the presence of KLF4 deficiencies upon OVA challenge 
(Fig 4). These observations expanded upon our previous findings of KLF4 regulation of 
MDSC differentiation to fibrocytes in cancer [17] and cutaneous wound healing [16], which 
collectively suggests a universal role of KLF4-mediated MDSC plasticity in inflammation-
related human diseases. However, the specific role of MDSC-derived fibrocytes in different 
systems needs to be investigated further.
TSLP is important in the development of asthma and other atopic diseases, such as the 
chronic inflammatory skin disease atopic dermatitis (AD). TSLP overexpression in mouse 
skin results in a spontaneous atopic dermatitis-like disease, whereas overexpression of TSLP 
in the lung, results in the development of severe airway inflammation and AHR [12]. Our 
current data showing the association of gene expression of KLF4 and TSLP in asthma, 
coupled with the role of KLF4 in wound healing and skin barrier formation, suggest that 
transcription factor KLF4 may directly regulate TSLP in lung and skin epithelial cells in 
these pathological processes. The presence of potential KLF4 binding sites in the mouse 
TSLP promoting region further confirmed this possibility (data not shown). Additional 
experiments, such as a chromatin immunoprecipitation assay to examine the binding of 
KLF4 to the TSLP promoter, and a reporter assay to assess the regulation of TSLP promoter 
activities by the overexpression of KLF4, will need to be performed to test the direct 
regulation of TSLP by KLF4. Moreover, it will be very intriguing to examine whether TSLP 
could rescue KLF4 deficiency-induced abnormalities in our asthma model. If confirmed, it 
will suggest a significant role for KLF4/TSLP signaling in asthma and potentially in AD and 
other skin diseases.
In conclusion, the current study reports that KLF4 promotes airway inflammation and 
remodeling in an acute mouse model of asthma. In addition, our data support the hypothesis 
that KLF4 expression in both monocytes and epithelial cells contributes to this process 
through promoting the differentiation of MDSCs to fibrocytes. In the epithelial cells, TSLP 
likely mediates the effect of KLF4 by increasing Th2 cytokine secretion leading to fibrocyte 
generation. Moreover, we speculate that MDSCs regulate airway inflammation and MDSC-
derived fibrocytes promote airway remodeling through EMT.
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• KLF4 in both MDSCs and lung epithelial cells controls asthma development
• TSLP likely mediates the effect of KLF4 in lung epithelial cells on asthma
• MDSC-expressing KLF4 promotes asthma in a fibrocyte-dependent manner
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Figure 1. Increased infiltration of MDSCs was accompanied by up-regulated gene expression of 
KLF4 and TSLP in the lung upon asthmatic challenge
A. An accute mouse model of allergic asthma as described in the Materials and Methods. i.p. 
represents intraperitoneal injection and i.n. represents intranasal injection. B. Mouse lung 
tissues were obtained, cut and mounted on slides, and PAS (Periodic Acid Schiff) staining 
performed. Red arrows indicated representative stain-positive goblet cells. C. IHC staining 
of KLF4 from control and OVA-challenged lung tissues using KLF4 antibodies. Red arrows 
indicate representative KLF4–positive epithelial cells.
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Figure 2. Increased infiltration of MDSCs was accompanied by up-regulated gene expression of 
KLF4 and TSLP in the lung upon asthmatic challenge
A. Mouse bronchoaveolar lavage fluids (BALF) were collected in control or OVA 
challenged mice, followed by cytokine measurement by ELISA. B. Single cells from lung 
tissues upon control or OVA challenge were purified, followed by flow cytometric analysis 
of MDSCs in the lung using CD11b and Ly6G antibodies. C. From the control and OVA 
challeged mice, total RNA from the lung tissues were extracted, cDNA were made and 
expression of KLF4 and FSP-1 in the lung were analysed by quantitative RT-PCR. * p<0.05 
between control and treatment groups, n=3.
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Figure 3. KLF4 ablation in CCR2+MDSCs in mice decreased TSLP expression in the lung and 
attenuated fibrocyte generation—establishment of FSP-1-Cre/KLF4(flox) mouse model
A. Total RNA from specific tissues as indicated were extracted and cDNA were made from 
the wild type (WT) and FSP-1-Cre/KLF4(flox) (KLF4−/−) mice. Gene expression of KLF4, 
FSP-1, CCR2, and TSLP were then analyzed by qRT-PCR. *p<0.05. B. KLF4 staining in the 
airway epithelial cells in the wild type (WT) and KLF4−/− mice were examined by IHC. C. 
Quantification of different serum cytokines by ELISA in the WT and KLF4−/− mice (n=3 in 
each group). *p<0.05. D. Fibrocyte generation from spleen cells of the WT and KLF4−/− 
mice were performed and the numbers of generated fibrocytes in each 105 spleen cells were 
plotted (n=3). **p<0.01
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Figure 4. Attenuated AHR and fibrosis in an acute model of allergic asthma in KLF4 knockout 
mice, accompanied by significantly decreased numbers of fibrocytes
A. Measurement of specific airway resistance (sRaw) by non-invasive whole-body 
plethysmography in the WT and KLF4−/− mice upon OVA challenge as described in the 
Materials and Methods. B. IL-13 expression levels in the lungs of the wild type (WT) and 
KLF4−/− mice upon control or OVA challenge were assessed by qRT-PCR. n=3, *p<0.05. C. 
Trichrome staining to examine lung fibrosis before and after OVA challenge in WT and 
KLF4−/− mice. Arrows point to possible fibrotic areas. D. After gating CD11b+Ly6G+ 
MDSCs, populations of CCR2+MDSCs in the lungs of WT and KLF4−/− mice before and 
after OVA challenge were measured by flow cytometry. E. Simiar to D, CD45+COL1A1+ 
fibrocytes in the lungs were measured by flow cytometry.
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